WT1 124-138 Peptide Vaccine

A synthetic peptide vaccine consisting of a HLA-DR15-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 124 through 138, a HLA class II-restricted WT1 peptide, with potential immunomodulating and antitumor activities. Vaccination with WT1 124-138 peptide may stimulate a CD4-positive helper T-lymphocyte-mediated immune response against WT1 expressing cells. Activated helper T-cells stimulate dendritic cells, and activate the proliferation of other T-lymphoctes and B-lymphocytes. This causes tumor cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing tumor cells. WT1, a zinc finger DNA-binding protein, is overexpressed in most types of leukemia and in a variety of solid cancers. (NCI Thesaurus)

YOU MAY ALSO LIKE

WS

An inherited disorder marked by rapid aging that begins in early adolescence. Patients may be shorter than average, and have health problems…

WRNIP1 wt Allele

Human WRNIP1 wild-type allele is located in the vicinity of 6p25.2 and is approximately 21 kb in length. This allele, which encodes…

WRNIP1 Gene

This gene is involved in both ATP hydrolysis and DNA replication.

WRN wt Allele

Human WRN wild-type allele is located within 8p12-p11.2 and is approximately 140 kb in length. This allele, which encodes Werner syndrome ATP-dependent…

WRN Gene

This gene is involved in DNA repair and the unwinding of DNA.

Written Language

Communication by means of words or symbols traced or formed on paper or another surface.